Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

30.25USD
17 Apr 2014
Price Change (% chg)

$0.16 (+0.53%)
Prev Close
$30.09
Open
$30.15
Day's High
$30.40
Day's Low
$30.07
Volume
10,228,944
Avg. Vol
7,169,549
52-wk High
$32.96
52-wk Low
$27.12

PFE.N

Chart for PFE.N

About

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company’s diversified global healthcare portfolio includes human... (more)

Overall

Beta: 0.74
Market Cap (Mil.): $193,404.30
Shares Outstanding (Mil.): 6,393.53
Dividend: 0.26
Yield (%): 3.44

Financials

  PFE.N Industry Sector
P/E (TTM): 18.33 33.26 33.35
EPS (TTM): 1.65 -- --
ROI: 7.49 19.66 18.92
ROE: 14.45 20.35 19.68
Search Stocks

UPDATE 2-Teva settles patent suit with Pfizer over Celebrex

April 17 - Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December.

17 Apr 2014

Teva, Pfizer settle patent lawsuit over blockbuster painkiller

- Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December.

17 Apr 2014

Teva, Pfizer settle patent lawsuit over painkiller Celebrex

April 17 - Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December.

17 Apr 2014

New kind of trial aims to speed cancer drug development

* AstraZeneca, Pfizer, UK charity link in multi-drug trial

16 Apr 2014

U.S. drug industry group defends price of Gilead hepatitis drug

WASHINGTON - The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

10 Apr 2014

U.S. drug industry group defends price of Gilead hepatitis drug

WASHINGTON, April 10 - The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

10 Apr 2014

Untaxed U.S. corporate profits held overseas top $2.1 trln -study

* Senate Finance Committee Chairman Wyden calls for reform

08 Apr 2014

US STOCKS-Wall Street falls on broad weakness, Pfizer drags

* Indexes down: Dow 0.77 pct, S&P 0.76 pct, Nasdaq 0.97 pct (Updates to midday)

07 Apr 2014

US STOCKS-Wall St flat as momentum stocks stabilize; Pfizer drags

* Dow down 0.17 pct, S&P down 0.08 pct, Nasdaq up 0.09 pct (Updates to open, adds quote)

07 Apr 2014

Pfizer drug doubles time to breast cancer tumor growth in trial

- Pfizer Inc's experimental breast cancer drug in a clinical trial nearly doubled the amount of time patients lived without their disease getting worse, but overall survival was not yet shown to be statistically significant, researchers said.

06 Apr 2014

Competitors

  Price Change
The Procter & Gamble Company (PG.N) $81.76 +0.11
Johnson & Johnson (JNJ.N) $98.96 +0.21
Novartis AG (NOVN.VX) CHF74.70 +0.35
Merck & Co., Inc. (MRK.N) $56.47 +0.21
Roche Holding Ltd. (ROG.VX) CHF254.90 +0.70
Abbott Laboratories (ABT.N) $38.93 +0.55
Bayer AG (BAYGn.DE) €93.59 +0.66
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.48 +0.71
AstraZeneca plc (AZN.L) 3,781.50p +23.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks